Opioid Misuse among Smokers with Chronic Pain: Relations with Substance Use and Mental Health.

IF 2 4区医学 Q3 BEHAVIORAL SCIENCES

Behavioral Medicine Pub Date : 2021-07-01 Epub Date: 2020-06-17 DOI:10.1080/08964289.2020.1742642

Michael J Zvolensky, Andrew H Rogers, Lorra Garey, Justin M Shepherd, Joseph W Ditre

{"title":"Opioid Misuse among Smokers with Chronic Pain: Relations with Substance Use and Mental Health.","authors":"Michael J Zvolensky, Andrew H Rogers, Lorra Garey, Justin M Shepherd, Joseph W Ditre","doi":"10.1080/08964289.2020.1742642","DOIUrl":null,"url":null,"abstract":"Opioid misuse is a significant public health concern with substantial medical, social, and economic costs. Cross cutting the personal and societal effects of this current crisis, opioid misuse is associated with poorer physical and mental health outcomes that impair function across numerous life domains. Importantly, opioid misuse disproportionately affects persons with chronic pain and individuals who smoke tobacco. Despite the higher risk for smokers with chronic pain to engage in opioid misuse, little work has examined how opioid misuse may be related to mental health problems, including other substance use, among this vulnerable group. The current study examined opioid misuse as a predictor of substance use and mental health problems among 187 (Mage = 39.02, SD = 9.94, 74.9% female) daily cigarette smokers with chronic pain who currently use opioids. Results indicated that opioid misuse is associated with greater tobacco (13% of variance), alcohol (27% of variance), and cannabis (22% of variance) problems, as well as anxiety (26% of variance) and depressive symptoms (26% of variance). These results highlight the potential importance of opioid misuse in terms of concurrent substance and mental health problems among smokers with chronic pain. Future work is needed to explicate directionality and temporal ordering in the observed relations.","PeriodicalId":55395,"journal":{"name":"Behavioral Medicine","volume":"47 4","pages":"335-343"},"PeriodicalIF":2.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08964289.2020.1742642","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavioral Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08964289.2020.1742642","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/6/17 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Opioid misuse is a significant public health concern with substantial medical, social, and economic costs. Cross cutting the personal and societal effects of this current crisis, opioid misuse is associated with poorer physical and mental health outcomes that impair function across numerous life domains. Importantly, opioid misuse disproportionately affects persons with chronic pain and individuals who smoke tobacco. Despite the higher risk for smokers with chronic pain to engage in opioid misuse, little work has examined how opioid misuse may be related to mental health problems, including other substance use, among this vulnerable group. The current study examined opioid misuse as a predictor of substance use and mental health problems among 187 (M_age = 39.02, SD = 9.94, 74.9% female) daily cigarette smokers with chronic pain who currently use opioids. Results indicated that opioid misuse is associated with greater tobacco (13% of variance), alcohol (27% of variance), and cannabis (22% of variance) problems, as well as anxiety (26% of variance) and depressive symptoms (26% of variance). These results highlight the potential importance of opioid misuse in terms of concurrent substance and mental health problems among smokers with chronic pain. Future work is needed to explicate directionality and temporal ordering in the observed relations.

查看原文本刊更多论文

慢性疼痛吸烟者阿片类药物滥用:与物质使用和心理健康的关系

阿片类药物滥用是一个重大的公共卫生问题，具有巨大的医疗、社会和经济成本。纵观当前这场危机对个人和社会的影响，阿片类药物滥用与身心健康状况恶化有关，损害了许多生活领域的功能。重要的是，阿片类药物滥用对慢性疼痛患者和吸烟个体的影响不成比例。尽管患有慢性疼痛的吸烟者滥用阿片类药物的风险较高，但很少有工作研究阿片类药物滥用如何与这一弱势群体的心理健康问题(包括其他物质使用)相关。本研究调查了187例(Mage = 39.02, SD = 9.94, 74.9%女性)每日吸烟且目前使用阿片类药物的慢性疼痛患者中阿片类药物滥用作为物质使用和精神健康问题的预测因子。结果表明，阿片类药物滥用与更严重的烟草(方差的13%)、酒精(方差的27%)和大麻(方差的22%)问题以及焦虑(方差的26%)和抑郁症状(方差的26%)有关。这些结果强调了阿片类药物滥用在慢性疼痛吸烟者中并发物质和精神健康问题方面的潜在重要性。需要进一步的工作来解释观察到的关系中的方向性和时序性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Behavioral Medicine 医学-行为科学

CiteScore

5.30

自引率

4.30%

发文量

审稿时长

>12 weeks

期刊介绍： Behavioral Medicine is a multidisciplinary peer-reviewed journal, which fosters and promotes the exchange of knowledge and the advancement of theory in the field of behavioral medicine, including but not limited to understandings of disease prevention, health promotion, health disparities, identification of health risk factors, and interventions designed to reduce health risks, ameliorate health disparities, enhancing all aspects of health. The journal seeks to advance knowledge and theory in these domains in all segments of the population and across the lifespan, in local, national, and global contexts, and with an emphasis on the synergies that exist between biological, psychological, psychosocial, and structural factors as they related to these areas of study and across health states. Behavioral Medicine publishes original empirical studies (experimental and observational research studies, quantitative and qualitative studies, evaluation studies) as well as clinical/case studies. The journal also publishes review articles, which provide systematic evaluations of the literature and propose alternative and innovative theoretical paradigms, as well as brief reports and responses to articles previously published in Behavioral Medicine.